[ Blueprint Genetics raises $15.96M in Series A ]
Blueprint Genetics has raised $15.96 million in Series A funding.
Founded in 2012, Blueprint Genetics is a healthcare firm that provides clinical sequencing and genetic testing services to patients.
The company plans to use the fresh cash to accelerate further growth, strengthen sales, expand its geographic presence and establish programs to further increase the efficiency of its sequencing platform and continue the development of its software component and data pool to make interpretation of genetic data more efficient.
|City||Helsinki, Southern Finland|
|Founder / CEO||Tommi Lehtonen|
|MedTech Innovation Partners|
|Previous Investors||Inventure Oy|